Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time.

Kumar, S K; Dispenzieri, A; Fraser, R; Mingwei, F; Akpek, G; Cornell, R; Kharfan-Dabaja, M; Freytes, C; Hashmi, S; Hildebrandt, G; Holmberg, L; Kyle, R; Lazarus, H; Lee, C; Mikhael, J; Nishihori, T; Tay, J; Usmani, S; Vesole, D; Vij, R; Wirk, B; Krishnan, A; Gasparetto, C; Mark, T; Nieto, Y; Hari, P; D'Souza, A

Kumar, S K; Dispenzieri, A; Fraser, R; Mingwei, F; Akpek, G; Cornell, R; Kharfan-Dabaja, M; Freytes, C; Hashmi, S; Hildebrandt, G; Holmberg, L; Kyle, R; Lazarus, H; Lee, C; Mikhael, J; Nishihori, T; Tay, J; Usmani, S; Vesole, D; Vij, R; Wirk, B; Krishnan, A; Gasparetto, C; Mark, T; Nieto, Y; Hari, P; D'Souza, A.

Affiliation

Kumar SK; Mayo Clinic Rochester, Rochester, MN, USA.
Dispenzieri A; Mayo Clinic Rochester, Rochester, MN, USA.
Fraser R; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Mingwei F; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Akpek G; Department of Internal Medicine, Rush University, Chicago, IL, USA.
Cornell R; Division of Hematology/Oncology Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Kharfan-Dabaja M; Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Freytes C; South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio, TX, USA.
Hashmi S; Mayo Clinic Rochester, Rochester, MN, USA.
Hildebrandt G; Department of Medicine, University of Kentucky, Lexington, KY, USA.
Holmberg L; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Kyle R; Mayo Clinic Rochester, Rochester, MN, USA.
Lazarus H; Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA.
Lee C; Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Mikhael J; Mayo Clinic Arizona, Scottsdale, AZ, USA.
Nishihori T; Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Tay J; University of Ottawa, Ottawa, ON, Canada.
Usmani S; Department of Hematology and Medical Oncology, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA.
Vesole D; John Theurer Cancer Center at Hackensack UMC, Hackensack, NJ, USA.
Vij R; Division of Oncology, Washington University, St Louis, MS, USA.
Wirk B; Division of Bone Marrow Transplant, Seattle Cancer Care Alliance, Seattle, WA, USA.
Krishnan A; City of Hope National Medical Center, Duarte, CA, USA.
Gasparetto C; Duke University Medical Center, Durham, NC, USA.
Mark T; Division of Hematology, University of Colorado-Anschutz Medical College, Aurora, CO, USA.
Nieto Y; Mayo Clinic Arizona, Scottsdale, AZ, USA.
Hari P; Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
D'Souza A; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.

Leukemia ; 32(4): 986-995, 2018 04.

Article de En | MEDLINE | ID: mdl-29263438

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Myélome multiple Type d'étude: Prognostic_studies Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Leukemia Sujet du journal: HEMATOLOGIA / NEOPLASIAS Année: 2018 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google